Table 1 Demographic and clinical characteristics of the study population.
Characteristics | Before PSM | After PSM | ||||
|---|---|---|---|---|---|---|
Death (n = 110) | Survival (n = 787) | P | Death (n = 107) | Survival (n = 107) | P | |
*Age (year) | 67.5 (57.0–81.0) | 57.0 (46.0–71.0) | < 0.001 | 69.5 (57.5–81.0) | 70.0 (60.0–81.0) | 0.836 |
*Gender (Male) | 57 (51.8) | 466 (59.2) | 0.141 | 55 (51.4) | 55 (51.4) | 1.000 |
LOS ICU (day) | 5.4 (1.6–12.8) | 2.8 (1.4–5.9) | 0.001 | 4.3 (1.5–11.4) | 2.2 (1.2–4.3) | < 0.001 |
LOS HOS(day) | 10.8 (3.4–19.5) | 11.4 (6.5–20.0) | 0.487 | 12.9 (3.5–21.5) | 10.8 (5.9–19.0) | 0.943 |
*CCI | 6 (5–8) | 4 (2–6) | < 0.001 | 6 (5–8) | 6 (4–7) | 0.197 |
Laboratory measurements | ||||||
RBC(1012/L) | 3.4 (2.9–4.1) | 3.7 (3.2–4.2) | < 0.001 | 3.4 (2.8–4.1) | 3.7 (3.2–4.2) | 0.010 |
WBC(109/L) | 14.6 (9.3–21.0) | 12.4 (8.6–17.4) | 0.007 | 14.1 (9.4–19.6) | 12.9 (8.8–19.8) | 0.197 |
PLT(109/L) | 146 (93–239) | 190 (137–265) | 0.002 | 152 (96–250) | 193 (144–280) | 0.017 |
AG(mmol/L) | 18.0 (14.5–22.0) | 15.0 (13.0–17.5) | < 0.001 | 17.5 (14.0–21.3) | 15.0 (13.0–16.5) | < 0.001 |
Cr(ng/dL) | 1.8 (1.2–3.3) | 1.0 (0.7–1.7) | < 0.001 | 1.7 (1.1–3.0) | 1.1 (0.8–1.6) | < 0.001 |
INR | 1.5 (1.3–2.1) | 1.3 (1.2–1.5) | < 0.001 | 1.5 (1.3–2.0) | 1.4 (1.2–1.6) | 0.002 |
Vital signs | ||||||
HR(bpm) | 93 (86–109) | 95 (81–108) | 0.290 | 95 (87–110) | 91 (78–106) | 0.029 |
SBP (mmHg) | 108 (100–119) | 123 (111–137) | < 0.001 | 108 (100–119) | 125 (110–139) | < 0.001 |
DBP (mmHg) | 59 (53–67) | 69 (61–78) | < 0.001 | 59 (53–68) | 67 (56–74) | 0.012 |
RR(cpm) | 22 (19–25) | 20 (17–23) | < 0.001 | 22 (20–25) | 20 (18–22) | < 0.001 |
T(℃) | 36.8 (36.4–37.2) | 37.0 (36.7–37.4) | < 0.001 | 36.8 (36.5–37.2) | 36.8 (36.6–37.1) | 0.184 |
RDW (%) | 15.75 (14.43–17.45) | 14.54 (13.60–15.69) | < 0.001 | 15.67 (14.43–17.25) | 14.87 (13.95–15.75) | < 0.001 |
BISAP score | 3 (3–4) | 2 (2–3) | < 0.001 | 3 (3–4) | 3 (2–4) | 0.001 |
SOFA score | 12 (8–15) | 5 (3–8) | < 0.001 | 11 (7–14) | 5 (3–7) | < 0.001 |